Koninklijke Philips PHG
NYSE PHG
$27.42 -0.08 (-0.29%)
At close: Aug 21, 2026 · 4:00 PM EDT

Koninklijke Philips (PHG) Cash from Investing Activities (2009 - 2026)

Koninklijke Philips (PHG) posted quarterly Cash from Investing Activities of -$22.1 million for Q2 2026, up 91.33% year-over-year from -$11.5 million in Q2 2025, and up 95.35% quarter-over-quarter from -$475.3 million in Q1 2026.

Koninklijke Philips (PHG) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Koninklijke Philips' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$22.1 million for Q2 2026.

  • In Q2 2026, Cash from Investing Activities rose 91.33% year-over-year to -$22.1 million; the TTM figure through Jun 2026 stood at -$2.0 billion (down 28.02% YoY), while the FY2025 annual figure was -$857.9 million, down 40.11% from the prior year.
  • Cash from Investing Activities for Q2 2026 stood at -$22.1 million, up from -$475.3 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was -$22.1 million in Q2 2026, with the low at -$1.5 billion in Q4 2022.
  • The 5-year median for Cash from Investing Activities is -$497.9 million (2026), against an average of -$531.0 million.
  • Peak annual rise in Cash from Investing Activities reached 91.33% in 2026, while the deepest fall reached 187.82% in 2026.
  • Koninklijke Philips' Cash from Investing Activities stood at -$1.5 billion in 2022, then surged by 54.89% to -$684.3 million in 2023, then climbed by 10.52% to -$612.3 million in 2024, then tumbled by 40.11% to -$857.9 million in 2025, then surged by 97.43% to -$22.1 million in 2026.
  • Business Quant data shows PHG's Cash from Investing Activities at -$22.1 million in Q2 2026, -$475.3 million in Q1 2026, and -$857.9 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -673.00 Mn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -639.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -193.20 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -22.08 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -108.50 Mn
10 Zimmer Biomet Holdings 19.42 Bn 19.01 Bn 1.54 Bn -190.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -22.08 Mn
Jun 30, 2026 -22.08 Mn
Mar 31, 2026 -475.32 Mn
Mar 31, 2026 -475.32 Mn
Dec 31, 2025 -857.90 Mn
Dec 31, 2025 -857.90 Mn
Sep 30, 2025 -632.46 Mn
Sep 30, 2025 -632.46 Mn
Jun 30, 2025 -254.69 Mn
Jun 30, 2025 -254.69 Mn
Mar 31, 2025 -165.15 Mn
Mar 31, 2025 -165.15 Mn
Dec 31, 2024 -612.31 Mn
Dec 31, 2024 -612.31 Mn
Sep 30, 2024 -520.56 Mn
Sep 30, 2024 -520.56 Mn
Jun 30, 2024 -175.53 Mn
Jun 30, 2024 -175.53 Mn
Mar 31, 2024 -190.11 Mn
Mar 31, 2024 -190.11 Mn